BURLINGAME, Calif.--(BUSINESS WIRE)--Neugenesis Corporation today announced a collaboration with PATH to develop an influenza vaccine production system. Under the agreement, Neugenesis will conduct proof of concept work to demonstrate the utility of the NeuBIOS™ protein production platform for making seasonal and pandemic influenza vaccine.
